Monday, May 25th
Last update08:11:21 AM GMT
The Food and Drug Administration said Thursday that it will sharply limit access to the anti- diabetes drug Avandia because of concerns about an increased cardiovascular risk associated with the drug.
Patients who are now taking the drug will have to sign an informed consent statement acknowledging that they understand all the risks before they will be allowed to continue refilling prescriptions.
 Congolese authorities say that suspected Ebola cases have now passed 900 in the ongoing outbreak in... |
 By the time the American surgeon who contracted Ebola in Congo was flown to Germany for... | ||
 When abortion restrictions are in the news, as they have been for several weeks, research shows... |
 Yet another item that may be in your pantry has been recalled over possible salmonella contamination.
A... |
